BIRC3 and B-cell chronic lymphocytic leukemia: Ex vivo experiments in primary del(11q) CLL cases revealed that del(11q) patients encompassing BIRC3 within the deleted region had higher NIK levels as well as p52-RelB activity, which correlated with BCL2 overexpression.